Based on this discovery, we proposed that the detected CD8+ lymphocytes were indeed tumor-specific CD8+ T cells summoned to particularly aggressive tumors, but lacking functionality due to immunosuppression, for example due to activation of the PD-1 pathway. Here, CD8A is linked to neoplasm.